Last reviewed · How we verify
Controlled Hypotension — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Sodium Nitroprusside | NITROPRUSSIDE | Roche | Vasodilator | Atrial natriuretic peptide receptor 1 | 1974-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 1 drug in Controlled Hypotension
- Roche · 1 drug in Controlled Hypotension
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Controlled Hypotension:
- Controlled Hypotension treatment updates — RSS
- Controlled Hypotension treatment updates — Atom
- Controlled Hypotension treatment updates — JSON
Cite this brief
Drug Landscape (2026). Controlled Hypotension — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/controlled-hypotension. Accessed 2026-06-10.
Related
- Controlled Hypotension full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing